Carasent ASA (ST:CARA) — Market Cap & Net Worth
Market Cap & Net Worth: Carasent ASA (CARA)
Carasent ASA (ST:CARA) has a market capitalization of $171.23 Million (Skr1.59 Billion) as of August 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #17109 globally and #293 in its home market, demonstrating a -0.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carasent ASA's stock price Skr23.80 by its total outstanding shares 66854305 (66.85 Million). See Carasent ASA capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Carasent ASA Market Cap History: 2024 to 2026
Carasent ASA's market capitalization history from 2024 to 2026. Data shows growth from $159.72 Million to $171.23 Million (4.89% CAGR).
Carasent ASA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carasent ASA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.57x
Carasent ASA's market cap is 0.57 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.70x
Carasent ASA's market cap is 5.70 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $159.72 Million | $275.26 Million | -$42.26 Million | 0.58x | N/A |
| 2025 | $197.49 Million | $343.82 Million | $34.67 Million | 0.57x | 5.70x |
Competitor Companies of CARA by Market Capitalization
Companies near Carasent ASA in the global market cap rankings as of August 4, 2026.
Key companies related to Carasent ASA by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #982 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1913 globally with a market cap of $12.17 Billion USD ( AU$17.21 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2124 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2588 globally with a market cap of $8.00 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #982 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $206.25 |
| #1913 | Pro Medicus Ltd | AU:PME | $12.17 Billion | AU$164.69 |
| #2124 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $60.47 |
| #2588 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.00 Billion | $46.05 |
Carasent ASA Historical Marketcap From 2024 to 2026
Between 2024 and today, Carasent ASA's market cap moved from $159.72 Million to $ 171.23 Million, with a yearly change of 4.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr171.23 Million | -13.30% |
| 2025 | Skr197.49 Million | +23.65% |
| 2024 | Skr159.72 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Carasent ASA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $171.23 Million USD |
| MoneyControl | $171.23 Million USD |
| MarketWatch | $171.23 Million USD |
| marketcap.company | $171.23 Million USD |
| Reuters | $171.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Carasent ASA
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient comm… Read more